Analysts at BTIG moved to the sidelines on online dating apps company Match Group (NASDAQ:MTCH) and lowered its investment ...

BTIG analyst Jake Fuller upgraded Instacart (CART) to Buy from Neutral with a $58 price target The immediate catalyst for the upgrade is a ...

DA Davidson upgraded Clearwater Analytics (CWAN) to Buy from Neutral with a price target of $32, down from $35. The company's ...

BTIG analyst Mark Massaro maintained a Buy rating on Castle Biosciences (CSTL – Research Report) today and set a price target of $40.00. The ...

In recent trading, P3 Health Partners Inc (PIII) stock price has shown some volatility, fluctuating -13.35% over the last five trades a ...

Fintel reports that on January 10, 2025, BTIG initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation.

BTIG's Krinsky noted that while equity markets in the first half of 2024 were fueled mostly by the surge in mega-cap names ...

Jonathan Krinsky, chief market technician at BTIG, joins CNBC's 'The Exchange to discuss his outlook on stocks for 2025, what ...

On Monday, IREN Ltd (IREN) stock saw a decline, ending the day at $10.46 which represents a decrease of $-0.54 or -4.91% from the prior close of $11. The stock opened at $10.32 and touched a low of $9 ...

On Friday, BTIG initiated coverage on ImmunityBio Inc (NASDAQ:IBRX) with a Buy rating and a price target of $6.00. The firm sees potential in the company's lead product, ANKTIVA, an IL-15 receptor ...

BTIG analyst Thomas Shrader lowered the firm’s price target on Denali Therapeutics (DNLI) to $32 from $35 and keeps a Buy rating on the shares after the company announced topline data from the ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Palo Alto Networks (BIT:1PANW) from Buy to Neutral. There are 3,043 funds or institutions reporting positions in Palo Alto ...